Related Experiment Video

Updated: Oct 11, 2025

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

19.8K

MicroRNA-34a Alleviates Gemcitabine Resistance in Pancreatic Cancer by Repression of Cancer Stem Cell Renewal

Yue Pan1, Kun Li1, Xufeng Tao1

  • 1From the State Key Laboratory of Fine Chemicals, Department of Pharmaceutical Sciences, School of Chemical Engineering, Dalian University of Technology, Dalian.

Pancreas
|December 3, 2021
PubMed
Abstract

Insights

MicroRNA-34a (miR-34a) enhances gemcitabine sensitivity in pancreatic cancer by targeting Notch 1. This finding suggests miR-34a as a potential therapeutic for gemcitabine-resistant pancreatic ductal adenocarcinoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignancy with limited treatment options.
  • Gemcitabine resistance is a major challenge in PDAC therapy.
  • MicroRNAs play crucial roles in cancer development and progression.

Purpose of the Study:

  • To investigate the role of microRNA-34a (miR-34a) in enhancing gemcitabine sensitivity in PDAC.
  • To determine if miR-34a targets Notch 1 signaling in PDAC cells.

Main Methods:

  • Cell viability was assessed using MTT assays.
  • Gene and protein expression levels were analyzed by qPCR and Western blotting.
  • Cellular stemness, invasiveness, and sphere formation were evaluated.
  • In vivo efficacy was tested in a transplanted tumor model.

Main Results:

  • miR-34a significantly enhanced gemcitabine sensitivity in PDAC cells both in vitro and in vivo.
  • miR-34a suppressed the stemness and proliferation of pancreatic cancer stem cells.
  • miR-34a directly targeted Notch 1, a key regulator of epithelial-mesenchymal transition (EMT) signaling.

Conclusions:

  • miR-34a sensitizes PDAC cells to gemcitabine by inhibiting Notch 1 signaling.
  • miR-34a demonstrates potential as a novel therapeutic agent for gemcitabine-resistant PDAC.

More Related Videos

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

8.5K
Isolation of Stem Cells from Human Pancreatic Cancer Xenografts11:44

Isolation of Stem Cells from Human Pancreatic Cancer Xenografts

Published on: September 26, 2010

22.5K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.2K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.1K